Lundbeck, Servier May Get EU Antitrust Complaints, Reuters Says

H. Lundbeck A/S (LUN) and Les Laboratoires Servier may be sent antitrust complaints by European Union regulators this week over hampering the sale of generic versions of branded drugs, Reuters reported.

Anders Schroll, a spokesman for Lundbeck in Copenhagen, said the company hadn’t received any formal notification from EU regulators.

Lucy Vincent, a spokeswoman for Servier, and Antoine Colombani, a spokesman for the European Commission in Brussels, didn’t immediately respond to e-mails seeking comment on the report.

To contact the reporter on this story: Aoife White in Brussels at awhite62@bloomberg.net.

To contact the editor responsible for this story: Anthony Aarons at aaarons@bloomberg.net.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.